The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family

被引:41
作者
Davidson, Sean M. [1 ,2 ]
Rybka, Aneta E. [3 ]
Townsend, Paul A. [3 ]
机构
[1] Univ Coll London Hosp, Hatter Cardiovasc Inst, London WC1E 6HX, England
[2] Sch Med, London WC1E 6HX, England
[3] Univ Southampton, Southampton Gen Hosp, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
Urocortin; Cardiovascular; Cardioprotection; Heart failure; Ischemia and reperfusion; MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA-REPERFUSION INJURY; PROTEIN-KINASE-C; CARDIAC MYOCYTES; SKELETAL-MUSCLE; TUMOR-GROWTH; HUMAN HEART; EXPRESSION; PEPTIDES; PATHWAYS;
D O I
10.1016/j.bcp.2008.08.033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The urocortins are members of the corticotropin releasing hormone (CRH) family of peptide hormones. The archetypal member of this family, CRH, plays an important role in regulating thermogenesis and homeostasis by acting centrally and systemically in target organs via its two receptors CRH-R1 and CRH-R2. However, by virtue of their much greater relative affinity for CRH-R2, the physiological effects of the urocortin peptides are largely restricted to peripheral organs such as the heart. A powerful cytoprotective effect of urocortin peptide administration against ischemia and reperfusion injury has been demonstrated in isolated cardiomyocyte models, as well as in the intact heart both in vitro and in vivo. Extremely promising data has shown the beneficial effect of treating pacing-induced heart failure in sheep with urocortin molecules. Though the efficacy and specificity of these molecules in humans is not yet established, molecular dissection of the cytoprotective pathways activated by urocortin peptides suggests that the beneficial effects may be separable from potentially deleterious effects. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 90 条
[81]   Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart [J].
Terui, K ;
Higashiyama, A ;
Horiba, N ;
Furukawa, KI ;
Motomura, S ;
Suda, T .
JOURNAL OF ENDOCRINOLOGY, 2001, 169 (01) :177-183
[82]   Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress [J].
Townsend, Paul A. ;
Davidson, Sean M. ;
Clarke, Samantha J. ;
Khaliulin, Igor ;
Carroll, Christopher J. ;
Scarabelli, Tiziano M. ;
Knight, Richard A. ;
Stephanou, Anastasis ;
Latchman, David S. ;
Halestrap, Andrew P. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (02) :H928-H938
[83]   Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-α release from macrophages via induction of COX-2 and PGE2 [J].
Tsatsanis, Christos ;
Androulidaki, Ariadne ;
Dermitzaki, Erini ;
Gravanis, Achille ;
Margioris, Andrew N. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 210 (03) :774-783
[84]   Urocortin in the synovial tissue of patients with rheumatoid arthritis [J].
Uzuki, M ;
Sasano, H ;
Muramatsu, Y ;
Totsune, K ;
Takahashi, K ;
Oki, Y ;
Iino, K ;
Sawai, T .
CLINICAL SCIENCE, 2001, 100 (06) :577-589
[85]   UROCORTIN, A MAMMALIAN NEUROPEPTIDE RELATED TO FISH UROTENSIN-I AND TO CORTICOTROPIN-RELEASING FACTOR [J].
VAUGHAN, J ;
DONALDSON, C ;
BITTENCOURT, J ;
PERRIN, MH ;
LEWIS, K ;
SUTTON, S ;
CHAN, R ;
TURNBULL, AV ;
LOVEJOY, D ;
RIVIER, C ;
RIVIER, J ;
SAWCHENKO, PE ;
VALE, W .
NATURE, 1995, 378 (6554) :287-292
[86]   Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2 [J].
Wang, Juejin ;
Xu, Youhua ;
Xu, Yinyan ;
Zhu, Huayuan ;
Zhang, Rongjian ;
Zhang, Guoxin ;
Li, Shengnan .
CANCER INVESTIGATION, 2008, 26 (04) :359-368
[87]   Expression of urocortin in rat lung and its effect on pulmonary vascular permeability [J].
Wu, YQ ;
Xu, YY ;
Zhou, H ;
Tao, J ;
Li, SN .
JOURNAL OF ENDOCRINOLOGY, 2006, 189 (01) :167-178
[88]   Enhanced expression of urocortin in lung tissues of rats with allergic asthma [J].
Wu, YQ ;
Zhou, H ;
Xu, YY ;
Li, SG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (02) :532-540
[89]  
Yao XQ, 2002, J CARDIAC SURG, V17, P347
[90]   Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BGL-X(L) [J].
Zha, JP ;
Harada, H ;
Yang, E ;
Jockel, J ;
Korsmeyer, SJ .
CELL, 1996, 87 (04) :619-628